Our ipomoeassin research on protein translocation recently received funding support from NIH.  With the financial aid, we will continue to develop new structural and functional chemical entities derived from ipomoeassin F to investigate Sec61-mediated protein biogenesis for its pharmaceutical potential.  We will actively recruit and train graduate and undergraduate students to prepare them well for their future career in biomedical professions.